RS Biotherapeutics is a company on a mission. Specifically, to “develop life-changing medicines for the millions of people suffering from diseases characterized by pulmonary inflammation.”
When this exciting new company was looking for extra capital to grow it operations, it turned to Reg CF, the SEC exemption that allows private companies to accept investment from everyone.
The company recently closed its Reg CF round on the StartEngine platform with nearly $200k in extra capital.
Congratulations RS Bio!
By Jossey PLLC
Jossey PLLC performed paid legal work for this raise.
